HSP47 inhibitor Col003 attenuates thromboinflammation after cerebral ischemia-reperfusion by suppressing GPVI-mediated CD84 shedding in platelets
Authors:
- 22 May 2026
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 195, 186-197
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82160236)
- Natural Science Foundation of Guangxi Province
This publication has 49 references indexed in Scilit:
- Sibakazin: a novel black fly derived non-classical kazal protease inhibitor, targeting antiplatelet (P2Y12/GPVI) pathways without perturbing coagulationInsect Biochemistry and Molecular Biology, 2026
- HSP47 inhibitor Col003 inhibits glial scar formation and improves neurological function in ischemic stroke in ratsBrain Research Bulletin, 2026
- Peptide RL‐QN15 Regulates Functions of Epidermal Stem Cells to Accelerate Skin Wound Regeneration via the FZD8/β‐Catenin AxisExploration, 2025
- Cathelicidin-HG alleviates psoriasis by targeting glycoprotein VI to inhibit platelet-neutrophil complexes formationEuropean Journal of Pharmacology, 2025
- Prevalence and influencing factors of patient delay in stroke patients: a systematic review and meta-analysisNeurosurgical Review, 2024
- Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular TreatmentJAMA Neurology, 2023
- Thromboinflammatory challenges in stroke pathophysiologySeminars in Immunopathology, 2023
- Peptide OM-LV20 protects astrocytes against oxidative stress via the ‘PAC1R/JNK/TPH1’ axisJournal of Biological Chemistry, 2022
- CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disordersClinical Immunology, 2019
- Optimal Germinal Center Responses Require a Multistage T Cell:B Cell Adhesion Process Involving Integrins, SLAM-Associated Protein, and CD84Immunity, 2010